$8.840
+0.040 (+0.45%)收盘时
价格预测
在 App 中打开以解锁更长周期的预测。
BBOT 相似图表分析预测
Alphio's BBOT stock price prediction model matches the current BridgeBio Oncology Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $8.87 (+0.52%). The 1-week path is $8.66 (-1.80%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
该买入 BridgeBio Oncology Therapeutics Inc 股票吗？
Helix Acquisition Corp II (BBOT) is not a good buy right now due to its current price of $8.74, which is significantly below analyst price targets ranging from $22 to $29. The stock has a low RSI of 33.785, indicating it is oversold, but the negative catalysts such as a consistent decline in net income and a projected EPS of -0.71 suggest ongoing financial struggles. The main risk is the high forward P/E ratio of 0, indicating uncertainty in future earnings.
BBOT 股价于 Tuesday 收于 $8.84，此前上涨 +0.45%
BridgeBio Oncology Therapeutics Inc (BBOT) last closed at $8.82, gaining +0.23%. These facts feed the 1-day and 1-week BBOT price prediction above.
预测驱动因素
BridgeBio Oncology Therapeutics Inc（BBOT）的预测驱动因素综合了相似的图表形态、季节性与移动平均线。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bearish
SMA 200
Bearish
相似图表形态
近期走势与 BBOT 最接近的股票，按相似度排序。
BBOT 季节性分析
Historically the probability of a positive September return for BBOT is 77.27%. October offers the highest probability of a positive month at 100.00%, while February is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本页仅供研究参考，不构成投资建议。模型可能出错。过往表现不代表未来结果。